Cite

    Sabrina da Conceição Pereira et al.. “Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy.” Journal of cachexia, sarcopenia and muscle, vol. 12, no. 6, 2021, pp. 2122–2133. http://access.bl.uk/ark:/81055/vdc_100148191560.0x000007